Acumen Physician Solutions

  • Products
    • Acumen Epic Connect
    • Acumen Nephrologixx
  • Blog
  • Connect
    • Acumen Community
    • Events
  • About Us
    • Our Customers
    • Leadership Team
    • Careers
  • Contact Us
  • (877) 535-5566
  • Login
    • Acumen Dialysis &
      Hospital Rounding
    • Acumen Epic Connect

Meaningful Use and Nephrology

Terry Ketchersid, MD, MBA, Chief Medical Officer - Integrated Care Group
September 23, 2010 Leave a Comment

One of the most important topics at the intersection of nephrology and health IT is the CMS EHR incentive program. Starting next year nephrologists have the opportunity to earn $44,000 over the ensuing 5 years by demonstrating meaningful use of a certified EHR. Using a classic “carrot and stick” approach, CMS will begin reducing the Medicare physician fee schedule in 2015 for those unable to demonstrate meaningful use.

 

Sounds simple right? In fact, this program likely will present significant challenges for most nephrology practices. For 2011 and 2012 demonstrating meaningful use requires the nephrologist to report on 20 distinct stage 1 meaningful use objectives. Many objectives establish a threshold that must be exceeded. For example, at least 80% of patients encountered during the reporting period must have a problem record within their problem list (or a notation that the patient has no problems). Others require a simple “yes or no” answer to which the provider must attest. For example, a provider must attest to whether the EHR’s drug-drug and drug-allergy interaction features are enabled during the entire reporting period. If the answer is “no” because the interaction features were not enabled during the entirety of the reporting period, the provider will not succeed in demonstrating meaningful use.

 

Herein lies one of the challenges of the program. Demonstrating meaningful use employs an “all or none” structure. That is, if I successfully report 19 of 20 meaningful use objectives, but only 79% of my eligible patients have a problem on their problem list, I am not a meaningful user in the eyes of CMS, and I would not receive the financial incentive for the reporting year.

 

I will be visiting various aspects of meaningful use and its impact on nephrology in the coming weeks. In the meantime, here is an overview of the program. Next week I will explore the structure of the incentive in greater detail.

Related Posts

  • Meaningful Use and the High Threshold ObjectivesMeaningful Use and the High Threshold Objectives
  • Dialysis Encounters and Meaningful Use RevisitedDialysis Encounters and Meaningful Use Revisited
  • Meaningful Use Stage 3: Is It Final or Not?Meaningful Use Stage 3: Is It Final or Not?

Filed Under: Blog, Meaningful Use Tagged With: CMS, EHR, Meaningful Use, Nephrologists

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Interwell Health Celebrates 5M Patient Charts in Acumen Epic Connect
  • Acumen Achieves 2023 Epic Connect Accreditation!
  • The CMS Quality Payment Program: Future Impact on the Medicare Physician Fee Schedule
  • Raising the Bar: ETC Updates for 2022 Are In!
  • Telehealth: Current State/Future State

Blog Categories

Subscribe to our Blog

Acumen Community

Corporate Headquarters
1000 Corporate Centre Drive, Suite 400
Franklin, TN 37067

(615) 567-4700
(877) 535-5566 Toll Free
(615) 567-4705 Fax

Search this site

Acumen Physician Solutions is an InterWell Health company.

  • Facebook
  • LinkedIn
  • Twitter
Copyright © Acumen Physician Solutions  •  User Agreement and Privacy Policy